O'Reilly, Terry
75  Ergebnisse:
Personensuche X
?
3

A Randomized, Double‐Blind, Parallel Design Thorough QT Stu..:

Lee, Jimin ; Lester, Robert ; O'Reilly, Terry...
Clinical Pharmacology in Drug Development.  12 (2023)  3 - p. 236-248 , 2023
 
?
6

Pharmacokinetics and Macrophage Inhibitory Cytokine‐1 Pharm..:

Wong, Shekman ; Krejsa, Cecile ; Lee, Dana...
Clinical Pharmacology in Drug Development.  11 (2022)  5 - p. 640-653 , 2022
 
?
8

SAFETY OF AMISELIMOD IN HEALTHY SUBJECTS: RESULTS FROM A PH..:

Hanauer, Stephen ; O'Reilly, Terry ; Lester, Robert...
Inflammatory Bowel Diseases.  27 (2021)  Supplement_1 - p. S1-S1 , 2021
 
?
9

Inhibition of fatty acid synthase with FT‐4101 safely reduc..:

Beysen, Carine ; Schroeder, Patricia ; Wu, Eric...
Diabetes, Obesity and Metabolism.  23 (2020)  3 - p. 700-710 , 2020
 
?
10

A large multicentre, randomized, double‐blind, cross‐over s..:

Bellon, Anne ; Wang, Jessie ; Skerjanec, Andrej...
British Journal of Clinical Pharmacology.  86 (2020)  6 - p. 1139-1149 , 2020
 
?
11

First‐in‐Human Study of AG10, a Novel, Oral, Specific, Sele..:

Fox, Jonathan C. ; Hellawell, Jennifer L. ; Rao, Satish...
Clinical Pharmacology in Drug Development.  9 (2019)  1 - p. 115-129 , 2019
 
?
12

SAT-430 A Phase 1 Study in Healthy Volunteers to Assess the..:

Kaviya, Arpeat ; O'Reilly, Terry ; Batonga, Joelle...
Journal of the Endocrine Society.  3 (2019)  Supplement_1 - p. , 2019
 
?
13

Lack of Effect of Rezafungin on QT/QTc Interval in Healthy ..:

Flanagan, Shawn ; Goodman, Daniel B. ; Jandourek, Alena..
Clinical Pharmacology in Drug Development.  9 (2019)  4 - p. 456-465 , 2019
 
?
14

2389. Effect of Rezafungin on QT Interval in Healthy Subjec..:

Flanagan, Shawn ; Goodman, Daniel B ; Rao, Pallavi...
Open Forum Infectious Diseases.  5 (2018)  suppl_1 - p. S712-S712 , 2018
 
1-15